Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.
Related healthcare insights
Article
Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.
Our quarterly e-newsletter helps you stay up to date with current issues facing life sciences leaders and the role of real-world evidence.
Article
Learn how real-world data and evidence can help prepare you for healthcare-related Inflation Reduction Act policies.